Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events
- Vera E. R. Asscher*
- , Quirine van der Vliet
- , Karen van der Aalst
- , Anniek van der Aalst
- , Eelco C. Brand
- , Andrea E. van der Meulen-de Jong
- , Bas Oldenburg
- , Marieke J. Pierik
- , Bas van Tuyl
- , Nofel Mahmmod
- , P. W. Jeroen Maljaars
- , Herma H. Fidder
- , Dutch ICC
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review